Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Mirum Pharmaceuticals
MIRM
$6.56B
| $69.5M | 0.04% |
2,767,210
+704,659
| +34% | +$19.4M |
|
327
Commercial Metals
CMC
$7.53B
| $68.2M | 0.04% |
1,159,769
+25,816
| +2% | +$1.37M |
|
328
CG Oncology
CGON
$6.1B
| $66.8M | 0.04% |
+1,521,432
| New | +$62.1M |
|
329
Doximity
DOCS
$3.89B
| $66.6M | 0.04% |
2,474,695
+621,590
| +34% | +$17.7M |
|
330
Insight Enterprises
NSIT
$3.85B
| $66.1M | 0.04% |
356,430
-107,990
| -23% | -$19.9M |
|
331
Roper Technologies
ROP
$40.4B
| $65.9M | 0.04% |
117,522
-397
| -0.3% | -$217K |
|
332
Lazard
LAZ
$4B
| $65.6M | 0.04% |
+1,567,944
| New | +$61.1M |
|
333
Signet Jewelers
SIG
$3.84B
| $65.6M | 0.04% |
656,005
+181,207
| +38% | +$18.1M |
|
334
Booz Allen Hamilton
BAH
$8.44B
| $65.6M | 0.04% |
441,587
+92,122
| +26% | +$13M |
|
335
NNN REIT
NNN
$9.29B
| $65M | 0.04% |
1,520,514
-44,697
| -3% | -$1.86M |
|
336
SPX Corp
SPXC
$9.39B
| $63.9M | 0.03% |
518,997
-10,966
| -2% | -$1.19M |
|
|
MRO
337
DELISTED
Marathon Oil Corporation
MRO
| $63.1M | 0.03% |
2,225,585
+121,130
| +6% | +$2.92M |
|
338
Descartes Systems
DSGX
$6.68B
| $63.1M | 0.03% |
688,766
-25,437
| -4% | -$2.24M |
|
339
UDR
UDR
$12.9B
| $62.8M | 0.03% |
1,679,891
+292,848
| +21% | +$10.8M |
|
340
Wendy's
WEN
$1.46B
| $62.6M | 0.03% |
3,321,275
+68,356
| +2% | +$1.28M |
|
341
Alcon
ALC
$34B
| $62.6M | 0.03% |
753,693
+30,758
| +4% | +$2.47M |
|
|
PCH
342
DELISTED
PotlatchDeltic
PCH
| $61.9M | 0.03% |
1,316,743
+212,121
| +19% | +$9.77M |
|
343
MSC Industrial Direct
MSM
$6.76B
| $61.8M | 0.03% |
636,690
-1,117
| -0.2% | -$110K |
|
344
Cardinal Health
CAH
$53.7B
| $61.6M | 0.03% |
550,730
-79,454
| -13% | -$8.57M |
|
345
BioMarin Pharmaceuticals
BMRN
$11.9B
| $60.8M | 0.03% |
696,518
-2,093,825
| -75% | -$187M |
|
346
Lattice Semiconductor
LSCC
$16B
| $60.8M | 0.03% |
776,736
-1,610
| -0.2% | -$115K |
|
347
Entegris
ENTG
$16.3B
| $60.7M | 0.03% |
432,045
-51,252
| -11% | -$6.55M |
|
348
Insmed
INSM
$22.4B
| $60.5M | 0.03% |
2,229,463
+826,372
| +59% | +$23.1M |
|
349
Mine Safety
MSA
$6.79B
| $60.4M | 0.03% |
312,222
+293,872
| +1,601% | +$51.7M |
|
350
Kilroy Realty
KRC
$4.59B
| $60M | 0.03% |
1,648,027
+1,590,558
| +2,768% | +$58.7M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.